Related Experiment Video
Updated: Mar 18, 2026
10:26
Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids
Published on: October 21, 2022
2.6K
Characterization of Mitochondrial Double-Stranded RNA Levels in Non-Small Cell Lung Carcinoma
Matthew R Krieger1, Sandy Che-Eun S Lee2,3, Ting Fu4
1Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, California.
Cancer Research Communications
|March 16, 2026
Summary
Mitochondrial double-stranded RNA (mtdsRNA) accumulates in some non-small cell lung cancers but does not trigger immune responses. Upregulated mtdsRNA may indicate mitochondrial dysfunction and serve as a cancer marker.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- Mitochondrial double-stranded RNA (mtdsRNA) acts as a damage-associated molecular pattern (DAMP) indicating mitochondrial stress.
- Its presence in cancers is noted, but prevalence and function are understudied due to detection challenges.
- mtdsRNA detection is limited by technical difficulties with structured mitochondrial transcripts.
Purpose of the Study:
- To investigate the prevalence and role of mtdsRNA in non-small cell lung cancer (NSCLC).
- To computationally characterize mtdsRNA formation and its association with immune responses in NSCLC.
- To explore mtdsRNA as a potential biomarker for mitochondrial dysfunction in cancer.
Main Methods:
- Computational characterization of NSCLC cell lines to identify elevated light-strand transcripts.
- Stratification of NSCLC lines based on mtdsRNA abundance.
- RT-qPCR analysis to assess mtdsRNA levels and Type-I interferon (IFN-I) response, including USP18 transcript regulation.
- Strand-specific RT-qPCR to evaluate mitochondrial gene expression bias.
Main Results:
- Elevated light-strand transcripts, suggesting potential mtdsRNA formation, were identified in a subset of NSCLC cell lines.
- High cytoplasmic mtdsRNA levels did not correlate with a significant Type-I IFN-I response.
- Only USP18 transcripts showed significant regulation among tested IFN-I transcripts, indicating a partial or suppressed IFN-I response.
- No bias in mitochondrial gene expression was observed via strand-specific RT-qPCR.
Conclusions:
- Basal mtdsRNA accumulation is insufficient to activate IFN-I signaling in NSCLC and may be tolerated.
- NSCLC cells may possess adaptive mechanisms to manage mtdsRNA accumulation.
- mtdsRNA might have non-immunogenic roles in tumor biology.
- Upregulated mtdsRNA in NSCLC and other cancers suggests its potential as a marker for mitochondrial dysfunction.
